Filing metadata

Accession number
0001104659-20-010902
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Feb 04, 2020
Reporting period
Jan 31, 2020
Description
Insider transaction

Explore SEC Filings Hub